Article info
Special populations
Original research
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation
- Correspondence to Professor Jürg Hans Beer, Department of Medicine, Cantonal Hospital of Baden, Baden Cantonal Hospital, Baden, 5404, Switzerland; hansjuerg.beer{at}ksb.ch
Citation
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation
Publication history
- Received May 16, 2022
- Accepted November 17, 2022
- First published January 2, 2023.
Online issue publication
February 14, 2023
Article Versions
- Previous version (2 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.